United States Home Infusion Therapy Market Set for Robust Growth as Home-Based Healthcare Gains Momentum

United States Home Infusion Therapy Market Trends & Summary

The United States home infusion therapy market is projected to reach approximately US$ 20.59 billion by 2033, rising from US$ 10.26 billion in 2024, expanding at a compound annual growth rate (CAGR) of 8.05% between 2025 and 2033. This impressive growth trajectory is primarily driven by the increasing prevalence of chronic diseases, the advancement of home healthcare technologies, and a growing preference among patients for cost-effective and convenient treatment options that can be administered outside hospital settings.

Download Sample Report

Home infusion therapy represents one of the most transformative trends in modern healthcare delivery. Instead of remaining hospitalized for extended periods, patients can now receive intravenous medications, nutrition, or other specialized treatments from the comfort of their homes. This shift not only improves patient quality of life but also helps healthcare systems reduce costs and optimize hospital resources.

The report “United States Home Infusion Therapy Market & Forecast 2025–2033” analyzes the market across several segments, including applications such as anti-infective therapy, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parenteral nutrition, specialty pharmaceuticals, and others. It also evaluates products including infusion pumps, intravenous sets, IV cannulas, and needleless connectors. Additionally, the study covers regional performance across U.S. states and provides comprehensive company analysis.

United States Home Infusion Therapy Market Outlook

Home infusion therapy is a healthcare service where patients receive medications through intravenous (IV) or injectable delivery systems within their homes rather than in hospitals or clinics. Treatments may include antibiotics, chemotherapy drugs, hydration therapy, pain management medications, or nutritional support.

The growing adoption of this therapy model in the United States reflects a broader transformation in healthcare toward decentralized and patient-centered care. With advancements in infusion technologies, remote monitoring systems, and portable infusion pumps, patients can now receive high-quality care while maintaining independence and comfort.

The application of home infusion therapy spans a wide range of medical conditions. These include chronic illnesses such as cancer, diabetes, and autoimmune disorders, as well as acute infections that require long-term antibiotic administration. Postoperative care and nutrition therapy also commonly rely on infusion treatments.

Healthcare providers—including specialized nurses, pharmacists, and clinicians—play a vital role in administering and monitoring these therapies. Their involvement ensures safety, correct dosage, and treatment effectiveness. As healthcare systems increasingly prioritize value-based care and improved patient outcomes, home infusion therapy continues to gain momentum nationwide.

Growth Drivers in the United States Home Infusion Therapy Market

Growing Prevalence of Chronic Diseases

One of the most powerful drivers behind the home infusion therapy market in the United States is the rising burden of chronic diseases. Conditions such as diabetes, cardiovascular disease, cancer, and autoimmune disorders require continuous treatment and long-term medical management.

Home infusion therapy offers a practical solution for these patients by allowing them to receive essential treatments without frequent hospital visits. This reduces healthcare system costs while simultaneously improving patient comfort and convenience.

Demographic changes also play a critical role. The aging population in the United States continues to expand rapidly. The U.S. Census Bureau estimates that the population aged 65 and older will increase from 52 million in 2018 to nearly 95 million by 2060, representing approximately 23% of the total population. Older adults are more likely to require ongoing medical treatments, including infusion therapies.

Furthermore, the Centers for Disease Control and Prevention (CDC) reports that nearly 70% of individuals receiving home care services are aged 65 or older. As the elderly population grows, demand for home-based treatment solutions is expected to accelerate significantly.

Another important factor is the expansion of Medicare enrollment. The Medicare Payment Advisory Commission projects that enrollment could exceed 80 million beneficiaries by 2030, compared with 54 million in 2015. This expansion further supports the growth of home healthcare services, including infusion therapy.

Technological Advancements in Infusion Devices

Rapid technological innovation in medical devices has significantly improved the efficiency, safety, and accessibility of home infusion therapy. Portable infusion pumps, smart monitoring devices, and wireless connectivity technologies have made it possible for patients to receive complex treatments at home with minimal risk.

Modern infusion pumps are designed with advanced safety features that ensure accurate medication dosing and reduce the likelihood of administration errors. These devices often include digital controls, automated dosage calculations, and alarm systems that notify healthcare providers if irregularities occur.

Another important advancement is the integration of remote monitoring capabilities. Healthcare professionals can now monitor patient treatments in real time, allowing them to adjust therapies or intervene quickly if complications arise. This technology greatly enhances patient safety while maintaining the convenience of home treatment.

Innovation in pharmaceuticals also contributes to market growth. For example, in November 2023, Omnix Medical received U.S. FDA approval to initiate a Phase II clinical study for its novel anti-infective drug OMN6. Such developments expand treatment options available through home infusion therapy.

These technological advancements not only improve treatment outcomes but also encourage more healthcare providers to adopt home-based infusion care models.

Rising Demand for Patient-Centered Care

Healthcare delivery in the United States is increasingly shifting toward patient-centered care models that emphasize comfort, convenience, and individualized treatment approaches. Home infusion therapy aligns perfectly with these priorities.

Patients receiving treatment at home often experience less stress and improved emotional well-being compared with hospital-based care. The familiar environment of home can significantly enhance treatment adherence and overall recovery.

Healthcare providers also recognize the advantages of home-based therapy. Reduced hospital admissions, lower treatment costs, and improved patient satisfaction are strong incentives for healthcare systems to support this approach.

Data from BioMatrix Specialty Pharmacy reported in March 2023 highlighted that home infusion therapy significantly reduces infection risks compared with hospital treatments. In addition, patients often report better physical and mental health outcomes when treatments are administered at home.

Cost savings represent another major advantage. Avoiding hospital stays or outpatient clinic visits can substantially reduce healthcare expenses for both patients and insurers. As healthcare costs continue to rise across the United States, these economic benefits are likely to further accelerate adoption.

Challenges Facing the United States Home Infusion Therapy Market

High Costs of Infusion Equipment and Therapies

Despite its long-term cost advantages, home infusion therapy still faces challenges related to initial expenses. Infusion pumps, monitoring equipment, and specialized medications can involve significant upfront costs.

Many patients encounter financial barriers when attempting to access these therapies, particularly if insurance coverage is limited or reimbursement policies are complex. Navigating reimbursement procedures can also be time-consuming and confusing for both patients and healthcare providers.

These financial constraints may limit access for certain populations, slowing adoption in some regions of the country.

Limited Availability of Skilled Healthcare Professionals

Another key challenge affecting the home infusion therapy market is the shortage of skilled healthcare professionals. Trained nurses, pharmacists, and clinical specialists are required to safely administer and monitor infusion treatments.

As demand for home healthcare services increases, the availability of qualified professionals becomes increasingly strained. Rural and underserved areas often face the greatest difficulties in accessing trained personnel.

Without sufficient workforce capacity, healthcare providers may struggle to deliver consistent and high-quality home infusion services. Addressing workforce shortages through training programs and healthcare policy initiatives will be crucial for sustaining long-term market growth.

United States Anti-Infective Home Infusion Therapy Market

Anti-infective therapy represents one of the most significant segments within the home infusion therapy market. Infections such as sepsis, osteomyelitis, and complicated bacterial infections often require prolonged antibiotic treatments that can last several weeks.

Home infusion therapy allows patients to complete these treatment regimens without extended hospitalization. This approach not only improves patient comfort but also reduces healthcare costs and hospital overcrowding.

The growing incidence of antibiotic-resistant infections and the need for long-term intravenous antibiotics are expected to further drive demand in this segment.

United States Chemotherapy Home Infusion Therapy Market

The chemotherapy home infusion therapy segment is experiencing steady growth as technological advancements make cancer treatment more accessible outside hospital settings.

Portable infusion pumps and wearable devices allow cancer patients to receive chemotherapy treatments at home while maintaining regular daily routines. This greatly reduces the physical and emotional strain associated with frequent hospital visits.

For many patients, home-based chemotherapy improves overall quality of life during treatment. As cancer incidence continues to rise and oncology therapies become more advanced, this segment is expected to expand significantly.

United States Infusion Pumps Market

Infusion pumps are one of the most critical components of home infusion therapy. These devices control the precise delivery of medications, fluids, or nutrients into a patient’s bloodstream.

The U.S. infusion pump market has witnessed major technological innovations in recent years. Smart pumps equipped with wireless connectivity and advanced monitoring systems provide real-time data and automated safety alerts.

For instance, in January 2024, Infuzamed introduced a wearable infusion pump featuring advanced remote monitoring capabilities. Such innovations enhance patient safety and improve treatment accuracy, supporting the continued expansion of home infusion therapy.

United States Intravenous Sets Market

Intravenous sets are another essential component of home infusion therapy systems. These devices enable the safe and controlled administration of medications through IV lines.

As home healthcare adoption increases across the United States, demand for IV sets continues to grow. Patients with chronic illnesses, post-surgical recovery needs, or nutritional therapy requirements rely heavily on these systems.

The increasing shift toward patient-centered healthcare models ensures sustained growth for the IV sets segment.

Regional Insights: Key State Markets

Several U.S. states play significant roles in shaping the home infusion therapy market due to population size, healthcare infrastructure, and demographic trends.

California leads the market with its large and diverse population and advanced healthcare infrastructure. High rates of chronic disease and strong healthcare policies supporting home care services contribute to market growth in the state.

New York is also witnessing rapid adoption of home infusion therapy as healthcare providers seek to reduce hospital overcrowding and improve patient outcomes.

Texas, with its large population and increasing prevalence of chronic conditions, is experiencing strong growth in home infusion services. State initiatives aimed at improving healthcare access—particularly in rural areas—further support market expansion.

Florida represents another important regional market due to its rapidly aging population. As older residents increasingly require long-term medical treatments, home infusion therapy is becoming an essential healthcare solution across the state.

Market Segmentation

By Application

Anti-Infective

Endocrinology

Hydration Therapy

Chemotherapy

Enteral Nutrition

Parenteral Nutrition

Specialty Pharmaceuticals

Others

By Product

Infusion Pumps

Intravenous Sets

IV Cannulas

Needleless Connectors

By States

California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio, Georgia, New Jersey, Washington, North Carolina, Massachusetts, Virginia, Michigan, Maryland, Colorado, Tennessee, Indiana, Arizona, Minnesota, Wisconsin, Missouri, Connecticut, South Carolina, Oregon, Louisiana, Alabama, Kentucky, and the Rest of the United States.

Competitive Landscape

The United States home infusion therapy market features several leading companies that drive innovation and market expansion. Major players analyzed in the report include:

Baxter International Inc.

Becton Dickinson and Company

Eli Lilly & Company

Fresenius SE & Co. KGaA

ICU Medical Inc.

Option Care Health Inc.

Terumo Corporation

These companies focus on product innovation, partnerships, and expanding home healthcare services to strengthen their market presence.

Final Thoughts

The United States home infusion therapy market is entering a transformative growth phase as healthcare systems increasingly shift toward decentralized and patient-centered care models. With the market projected to surpass US$ 20.59 billion by 2033, the sector offers significant opportunities for healthcare providers, medical device manufacturers, and pharmaceutical companies.

Rising chronic disease prevalence, technological innovation in infusion devices, and growing demand for convenient treatment solutions are reshaping how medical care is delivered. While challenges such as high equipment costs and workforce shortages remain, continued innovation and supportive healthcare policies are expected to sustain long-term market growth.

As healthcare continues evolving toward more accessible and personalized treatment models, home infusion therapy is poised to become a cornerstone of modern medical care in the United States.